A feasibility study of lenvatinib plus pembrolizumab in Japanese patients with advanced solid tumors

被引：0
|
作者：
Shigehisa Kitano
Yutaka Fujiwara
Toshio Shimizu
Satoru Iwasa
Kan Yonemori
Shunsuke Kondo
Akihiko Shimomura
Takafumi Koyama
Takahiro Ebata
Hiroki Ikezawa
Nozomi Hayata
Yukinori Minoshima
Takuma Miura
Tomoki Kubota
Noboru Yamamoto
机构：
[1] National Cancer Center Hospital,Department of Experimental Therapeutics
[2] The Cancer Institute Hospital of JFCR,Department of Advanced Medical Development
[3] Aichi Cancer Center,Department of Thoracic Oncology
[4] National Center for Global Health and Medicine,Department of Breast and Medical Oncology
[5] Eisai Co.,Clinical Data Science Department
[6] Ltd,Clinical Pharmacology Science Department
[7] Eisai Co.,Japan and Asia Clinical Development Department
[8] Ltd,undefined
[9] Tsukuba Research Laboratories,undefined
[10] Eisai Co.,undefined
[11] Ltd,undefined
[12] Eisai Co.,undefined
[13] Ltd,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2022年 / 90卷
关键词：
Biomarkers; Lenvatinib; Pembrolizumab; Pharmacokinetics; Toxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：523 / 529
页数：6
相关论文
共 50 条
  • [21] A phase 1 study of lenvatinib, multiple receptor tyrosine kinase inhibitor, in Japanese patients with advanced solid tumors
    Shinji Nakamichi
    Hiroshi Nokihara
    Noboru Yamamoto
    Yasuhide Yamada
    Kazunori Honda
    Yosuke Tamura
    Hiroshi Wakui
    Tatsuya Sasaki
    Wataru Yusa
    Katsuki Fujino
    Tomohide Tamura
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 1153 - 1161
  • [22] A phase 1b trial of lenvatinib (LEN) plus pembrolizumab (PEM) in patients with selected solid tumors
    Taylor, M.
    Dutcus, C. E.
    Schmidt, E.
    Bagulho, T.
    Li, D.
    Shumaker, R.
    Rasco, D.
    ANNALS OF ONCOLOGY, 2016, 27
  • [23] Pembrolizumab Plus Lenvatinib Approved in Advanced Endometrial Carcinoma
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (11) : 610 - 610
  • [24] Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: Updated results.
    Makker, Vicky
    Rasco, Drew W.
    Vogelzang, Nicholas J.
    Messing, Mark
    Brose, Marcia S.
    Cohn, Allen Lee
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [25] A PHASE I AND DOSE-FINDING STUDY OF LENVATINIB (E7080) IN JAPANESE PATIENTS WITH ADVANCED SOLID TUMORS
    Yamamoto, N.
    Nokihara, H.
    Yamada, Y.
    Honda, K.
    Wakui, H.
    Sasaki, T.
    Yusa, W.
    Tamura, T.
    ANNALS OF ONCOLOGY, 2013, 24
  • [26] Pembrolizumab plus lenvatinib combination therapy for advanced endometrial carcinoma
    Walker, Christopher A.
    Spirtos, Alexandra N.
    Miller, David S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (04) : 361 - 368
  • [27] A PHASE IB TRIAL OF ZIV-AFLIBERCEPT PLUS PEMBROLIZUMAB IN PATIENTS WITH ADVANCED SOLID TUMORS
    Tyan, Kevin
    Rahma, Osama
    Giobbie-Hurder, Anita
    Brohl, Andrew
    Bedard, Philippe
    Renouf, Daniel
    Sharon, Elad
    Streicher, Howard
    Hathaway, Emma
    Cunningham, Rachel
    Manos, Michael
    Severgnini, Mariano
    Rodig, Scott
    Hodi, F. Stephen
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A402 - A404
  • [28] Lenvatinib plus pembrolizumab in Japanese patients with endometrial cancer: Results from Study 309/KEYNOTE-775
    Yonemori, Kan
    Yunokawa, Mayu
    Ushijima, Kimio
    Sakata, Jun
    Shikama, Ayumi
    Minobe, Shinichiro
    Usami, Tomoka
    Enomoto, Takayuki
    Takehara, Kazuhiro
    Hasegawa, Kosei
    Yamagami, Wataru
    Yamamoto, Keiko
    Han, Shirong
    Dutta, Lea
    Orlowski, Robert
    Miura, Takuma
    Makker, Vicky
    Fujiwara, Keiichi
    CANCER SCIENCE, 2022, 113 (10) : 3489 - 3497
  • [29] Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
    Motzer, Robert
    Alekseev, Boris
    Rha, Sun-Young
    Porta, Camillo
    Eto, Masatoshi
    Powles, Thomas
    Gruenwald, Viktor
    Hutson, Thomas E.
    Kopyltsov, Evgeny
    Mendez-Vidal, Maria J.
    Kozlov, Vadim
    Alyasova, Anna
    Hong, Sung-Hoo
    Kapoor, Anil
    Alonso Gordoa, Teresa
    Merchan, Jaime R.
    Winquist, Eric
    Maroto, Pablo
    Goh, Jeffrey C.
    Kim, Miso
    Gurney, Howard
    Patel, Vijay
    Peer, Avivit
    Procopio, Giuseppe
    Takagi, Toshio
    Melichar, Bohuslav
    Rolland, Frederic
    De Giorgi, Ugo
    Wong, Shirley
    Bedke, Jens
    Schmidinger, Manuela
    Dutcus, Corina E.
    Smith, Alan D.
    Dutta, Lea
    Mody, Kalgi
    Perini, Rodolfo F.
    Xing, Dongyuan
    Choueiri, Toni K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (14): : 1289 - 1300
  • [30] Pembrolizumab plus lenvatinib for all advanced endometrial cancer? Maybe not
    Paulino, Eduardo
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (04) : 579 - 579
12345